The Importance of Early Diagnosis and Intervention in Myopic CNV

Select a video to view:

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Powerful, rapid and long-term efficacy across indications

by Pravin U. Dugel MD

Pravin U. Dugel, MD, discusses the current evidence that demonstrates the rapid and long term outcomes that are achievable with ranibizumab across multiple retinal disorders including CNV. Dr. Dugel also comments on recent long-term data showing visual acuity gains can be maintained up to 7 years in nAMD patients.

48 video views since . 150 total series views.

Novartis Pharma AG

CH-4002 Basel, Switzerland ©2014 Novartis Pharma AG Dec 2014 GLRET/LUC/0274